Potentiation of antitumor activity of alpha-difluoromethyl ornithine by the immunomodulating peptide tuftsin.
D000818:Animals; D000970:Antineoplastic Agents; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D004357:Drug Synergism; D000518:Eflornithine; D007111:Immunity, Cellular; D008264:Macrophages / Q000276:immunology; D008545:Melanoma / Q000188:drug therapy* / Q000276:immunology; D051379:Mice; D008810:Mice, Inbred C57BL; D009368:Neoplasm Transplantation; D009952:Ornithine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D011073:Polyamines / Q000037:antagonists & inhibitors; D014405:Tuftsin / Q000627:therapeutic use*
D000970:Antineoplastic Agents; D011073:Polyamines; D009952:Ornithine; D014405:Tuftsin; D000518:Eflornithine